Experienced in Familial Hypertriglyceridemia

Sarah Elitzur

Tel Aviv, TA, IL 
Experienced in Familial Hypertriglyceridemia
Tel Aviv, TA, IL 
OverviewLocationsClinical Research

Overview

Sarah Elitzur practices in Tel Aviv, Israel. Ms. Elitzur is rated as an Experienced expert by MediFind in the treatment of Familial Hypertriglyceridemia. Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Ataxia-Telangiectasia, Nijmegen Breakage Syndrome, and Bone Marrow Transplant.

Her clinical research consists of co-authoring 69 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Familial Hypertriglyceridemia.

Gender
Female

Locations

Tel Aviv, TA, Israel
Other Locations
Petah Tiqwa, M, Israel
Aviv, Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
Enrollment Status: Active_not_recruiting
Publish Date: September 19, 2025
Intervention Type: Drug, Procedure, Other, Biological
Study Drugs: Cyclophosphamide, Cytarabine, Daunorubicin Hydrochloride, Dexamethasone, Dexrazoxane Hydrochloride, Doxorubicin, Etoposide, Filgrastim, Ifosfamide, Imatinib Mesylate, Leucovorin Calcium, Mercaptopurine, Methotrexate, Methylprednisolone, Pegaspargase, Prednisolone, Hydrocortisone, Thioguanine, Vincristine Sulfate
Study Phase: Phase 3

69 Total Publications

Risk factors for mortality and re-admission of children with hematological malignancies to the intensive care unit due to sepsis.
Risk factors for mortality and re-admission of children with hematological malignancies to the intensive care unit due to sepsis.
Journal: Leukemia & lymphoma
Published: June 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Elitzur's expertise for a condition
ConditionClose
    View All 23 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile